Zobrazeno 1 - 10
of 238
pro vyhledávání: '"Vasileios F, Panoulas"'
Autor:
Vasileios F. Panoulas, Javier Escaned, Jonathan M. Hill, Erin Barker, Karin Butler, Ali Almedhychy, Stelios I. Tsintzos, William W. O’Neill
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Revascularization completeness after percutaneous coronary intervention (PCI) is associated with improved long-term outcomes. Mechanical circulatory support [intra-aortic balloon pump (IABP) or Impella] is used during high-risk PCI (HR-PCI) to enhanc
Externí odkaz:
https://doaj.org/article/2a37d61ea94147f1adf4ac14940240a5
Publikováno v:
BMJ case reports. 14(7)
An 88-year-old woman presented to our hospital due to an 18-hour history of worsening central chest pain. She had a dual-chamber pacemaker due to second-degree Mobitz type II atrioventricular block implanted 10 years ago. Her risk factors included hy
Autor:
Vasileios F. Panoulas, Matteo Montorfano, Maurizio Taramasso, Gennaro Giustino, Giovanni La Canna, Azeem Latib, Antonio Colombo
Publikováno v:
Hellenic Journal of Cardiology, Vol 57, Iss 1, Pp 41-44 (2016)
Sutureless valves were designed in an attempt to simplify the aortic valve replacement procedure and reduce extracorporeal circuit time, whilst allowing complete excision of the calcified native valve using a minimally invasive approach. Elderly pati
Externí odkaz:
https://doaj.org/article/eac0c414f4494748af93bb6e48153137
Autor:
Alexandros Kouloubinis, Sofia Sofroniadou, Vasileios F. Panoulas, Konstantinos Makaritsis, Ioanna Revela, George Karavolias, Vasileios Voudris, Stamatios Adamopoulos
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 6, Iss C, Pp 85-90 (2015)
Background: Anthracycline-induced cardiotoxicity typically presents as congestive heart failure (CHF). As immuno-inflammatory activation and apoptosis are important mechanisms in the process of heart failure, the use of biomarkers that could detect c
Externí odkaz:
https://doaj.org/article/0eeeffabea2747b8964ab6aa7bbacf7c
Autor:
Rahim Kanji, Vasileios F Panoulas, Alison Duncan, Simon W Davies, Thomas F Luscher, Saeed S Mirsadraee, Deepa R J Arachchillage, Diana A Gorog
Publikováno v:
Cardiovascular Research. 118
Background Patients with severe aortic stenosis (AS) are at risk of both bleeding and thrombotic events. The high shear and flow rates across the stenotic aortic valve (AV) degrade von Willebrand factor high molecular weight multimers increasing blee
Publikováno v:
Interact Cardiovasc Thorac Surg
Summary A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was ‘is the quality-of-life (QoL) improvement after transcatheter aortic valve implantation (TAVI) equivalent to that achieved b
Publikováno v:
JACC. Cardiovascular interventions. 15(18)
Autor:
Vasileios F. Panoulas, Fabio De Robertis, Andre Rüdiger Simon, Ulrich Stock, Maria Monteagudo-Vela, Diana Garcia-Saez
Publikováno v:
Artificial Organs. 45:254-262
The Impella (Abiomed, Danvers, MA, USA) has become an important adjunct treatment modality in bridging patients with end-stage heart failure to recovery or orthotopic heart transplantation (HTx). We compared the outcome of patients directly bridged t
Autor:
Ying X Gue, Diana A. Gorog, Saeed Mirsadraee, Sanjay K Prasad, Rahim Kanji, Vasileios F. Panoulas
Publikováno v:
Structural Heart. 4:349-359
The introduction of transcatheter aortic valve implantation (TAVI) has revolutionised the management of aortic stenosis (AS), with procedure numbers rapidly increasing. Although there has been enth...
Autor:
Amit Kaura, Divaka Perera, Harry Hemingway, Jim Davies, Anoop D. Shah, B Glampson, Joe Omigie, Keith M. Channon, Sam Abbott, Darrel P. Francis, Narbeh Melikian, Ajay M. Shah, Paul Elliott, Kerrie Woods, Thomas W Johnson, Vasileios F. Panoulas, Bryan Williams, Graham M. Lord, Jonathan N Weber, Rajesh K. Kharbanda, Adam Trickey, Folkert W. Asselbergs, Riyaz Patel, Abdulrahim Mulla, Mark R Thursz, Michael O'Sullivan, Jamil Mayet, Jonathan A C Sterne
Publikováno v:
Lancet, 396(10251), 623-634. Elsevier Limited
Background Previous trials suggest lower long-term risk of mortality after invasive rather than non-invasive management of patients with non-ST elevation myocardial infarction (NSTEMI), but the trials excluded very elderly patients. We aimed to estim